Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada.
Saved in:
| Title: | Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada. |
|---|---|
| Authors: | Bhutani M; Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada, Kaplan A; Family Physician Airways Group of Canada, and University of Toronto, Toronto, Ontario, Canada, Kayaniyil S; Scientific Affairs, AstraZeneca, Mississauga, Canada, Jamieson K; Scientific Affairs, AstraZeneca, Mississauga, Canada, Ormsby R; Scientific Affairs, AstraZeneca, Mississauga, Canada, Bell J; BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom, Bhatt P; Milliman, New York, New York, United States, Carioto J; Milliman, New York, New York, United States, Pyenson B; Milliman, New York, New York, United States |
| Source: | Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2026 May 27; Vol. 13 (3), pp. 184-194. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: COPD Foundation Country of Publication: United States NLM ID: 101635411 Publication Model: Print Cited Medium: Print ISSN: 2372-952X (Print) Linking ISSN: 2372952X NLM ISO Abbreviation: Chronic Obstr Pulm Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2372-952X |
|---|---|
| DOI: | 10.15326/jcopdf.2025.0687 |
